정신 질환 치료 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
Psychotic Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1823904
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,558,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,713,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,724,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,178,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 정신 질환 치료 시장의 미래는 병원 약국, 소매 약국, 드러그스토어, E-Commerce 시장에서의 기회로 유망시되고 있습니다. 세계의 정신 질환 치료 시장은 2025-2031년에 CAGR 6.1%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 정신질환의 유병률 증가, 정신과 치료에 대한 인식 증가, 효과적인 의약품에 대한 수요 증가 등입니다.

정신질환 치료 시장의 새로운 동향

정신질환 치료 시장은 약품 개발의 획기적인 발전, 개인 맞춤형 치료의 중요성 증가, 디지털 기술의 통합을 특징으로 하는 역동적인 변화를 경험하고 있습니다. 이러한 새로운 동향은 치료 패러다임을 재정의하고, 정신질환을 관리하기 위한 보다 종합적이고 접근하기 쉬운 접근법을 촉진하고 있습니다.

이러한 새로운 동향은 보다 효과적이고 효과적인 약리학적 개입, 혁신적인 약물전달을 통한 환자 순응도 향상, 디지털 헬스(Digital Health)를 통한 접근성 및 참여도 향상, 치료에 대한 총체적이고 개별화된 접근 방식 촉진 등을 통해 정신질환 치료 시장을 크게 재편할 것으로 예측됩니다. 정신질환 치료제 시장을 재편하고 있습니다.

정신질환 치료 시장의 최근 동향

최근 정신질환 치료제 시장은 효능 개선, 환자 순응도 향상, 정신 헬스케어에 대한 보다 종합적인 접근 방식을 향한 업계의 강력한 추진력을 반영하여 몇 가지 매우 중요한 진전을 이루었습니다. 이러한 발전은 정신질환 환자의 복잡한 요구에 대응하기 위해 매우 중요합니다.

이러한 최근 동향은 다양한 기전을 통한 새로운 치료 옵션의 도입, 첨단 제형을 통한 복약 순응도 강화, 디지털 헬스 활용을 통한 접근성 및 결과 개선, 미충족 증상 영역에 대한 집중적인 노력 등 정신질환 치료 시장에 전반적으로 영향을 미치고 있으며 궁극적으로 전인적 환자 치료를 촉진할 수 있을 것으로 기대됩니다.

목차

제1장 개요

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 세계의 정신 질환 치료 시장 : 약제 유형별

제5장 세계의 정신 질환 치료 시장 : 적응증별

제6장 세계의 정신 질환 치료 시장 : 유통 채널별

제7장 지역 분석

제8장 북미의 정신 질환 치료 시장

제9장 유럽의 정신 질환 치료 시장

제10장 아시아태평양의 정신 질환 치료 시장

제11장 세계 기타 지역(ROW)의 정신 질환 치료 시장

제12장 경쟁 분석

제13장 기회와 전략 분석

제14장 밸류체인에서 주요 기업의 기업 개요

제15장 부록

KSA
영문 목차

영문목차

The future of the global psychotic disorder treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, drug store and e-commerce markets. The global psychotic disorder treatment market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of mental health disorders, the rising awareness about psychiatric treatments, and the growing demand for effective medications.

Emerging Trends in the Psychotic Disorder Treatment Market

The psychotic disorder treatment market is experiencing dynamic shifts, characterized by significant advancements in drug development, a growing emphasis on personalized care, and the integration of digital technologies. These emerging trends are redefining treatment paradigms and fostering a more holistic and accessible approach to managing mental health conditions.

These emerging trends are profoundly reshaping the psychotic disorder treatment market by offering more targeted and effective pharmacological interventions, improving patient adherence through innovative drug delivery, enhancing accessibility and engagement via digital health, and promoting a holistic, personalized approach to care.

Recent Developments in the Psychotic Disorder Treatment Market

The psychotic disorder treatment market has witnessed several pivotal recent developments, reflecting a strong industry drive towards improved efficacy, enhanced patient compliance, and a more comprehensive approach to mental health care. These advancements are crucial for addressing the complex needs of individuals with psychotic disorders.

These recent developments are collectively impacting the psychotic disorder treatment market by introducing novel treatment options with different mechanisms, enhancing medication adherence through advanced formulations, leveraging digital health for improved access and outcomes, and focusing on underserved symptom domains, ultimately advancing holistic patient care.

Strategic Growth Opportunities in the Psychotic Disorder Treatment Market

The psychotic disorder treatment market presents numerous strategic growth opportunities across key applications, driven by increasing disease prevalence, a focus on improving patient outcomes, and advancements in therapeutic approaches. Capitalizing on these opportunities requires targeted innovation and a patient-centric approach.

These strategic growth opportunities are profoundly impacting the psychotic disorder treatment market by directing R&D towards unmet needs, fostering innovation in drug delivery, and integrating digital solutions to enhance patient engagement and access. This diversification and patient-centric approach are crucial for advancing mental health care globally.

Psychotic Disorder Treatment Market Driver and Challenges

The psychotic disorder treatment market is influenced by a dynamic interplay of various technological, economic, and regulatory factors. Its growth trajectory is significantly propelled by drivers that boost demand and innovation, while simultaneously facing notable challenges that necessitate strategic adaptations for sustained expansion and broader market penetration.

The factors responsible for driving the psychotic disorder treatment market include:

1. Increasing Prevalence of Psychotic Disorders: The rising global incidence and diagnosis of psychotic disorders like schizophrenia and bipolar disorder are primary market drivers. Factors such as changing lifestyles, increased stress, and improved diagnostic capabilities contribute to an expanding patient pool requiring treatment.

2. Advancements in Antipsychotic Drug Development: Continuous R&D leading to newer generations of antipsychotics (atypical, third-generation) with improved efficacy, better side effect profiles, and novel mechanisms of action is a significant driver. This includes the development of long-acting injectables (LAIs) enhancing adherence.

3. Growing Awareness and Destigmatization of Mental Health: Increased public awareness campaigns, government initiatives, and reduced stigma surrounding mental illness encourage more individuals to seek diagnosis and treatment. This improved access to care directly translates into higher demand for therapeutic interventions.

4. Favorable Reimbursement Policies and Healthcare Spending: Enhanced healthcare coverage and increased government and private sector spending on mental health services in many countries are driving market growth. This improves patient access to medications and therapeutic support, especially in developed economies.

5. Integration of Digital Health and Telepsychiatry: The rapid adoption of digital therapeutics and telepsychiatry platforms, especially accelerated by recent global health events, significantly drives market access. These technologies facilitate remote consultations, medication management, and psychological support, overcoming geographical barriers.

Challenges in the psychotic disorder treatment market are:

1. High Cost of Novel Therapies: The development and commercialization of new, innovative antipsychotic drugs, particularly those with complex mechanisms or advanced formulations like LAIs, entail high R&D costs, leading to high prices that can limit patient access and reimbursement in some healthcare systems.

2. Medication Non-Adherence and Relapse Rates: Despite advancements, non-adherence to medication remains a significant challenge in managing chronic psychotic disorders, leading to frequent relapses and poorer patient outcomes. This necessitates continuous efforts in developing more convenient formulations and supportive interventions.

3. Persistent Stigma and Misconceptions: Despite growing awareness, societal stigma and misconceptions surrounding psychotic disorders can still deter individuals from seeking early diagnosis and consistent treatment. This impacts treatment initiation, adherence, and overall patient integration into society.

The psychotic disorder treatment market is dynamically driven by the increasing prevalence of mental illnesses, continuous innovation in drug development, and growing mental health awareness. However, significant challenges such as the high cost of advanced therapies, persistent issues with medication non-adherence, and enduring societal stigma demand concerted efforts from pharmaceutical companies, healthcare providers, and policymakers to ensure equitable access and optimal patient outcomes.

List of Psychotic Disorder Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psychotic disorder treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psychotic disorder treatment companies profiled in this report include-

Psychotic Disorder Treatment Market by Segment

The study includes a forecast for the global psychotic disorder treatment market by drug type, indication, distribution channel, and region.

Psychotic Disorder Treatment Market by Drug Type [Value from 2019 to 2031]:

Psychotic Disorder Treatment Market by Indication [Value from 2019 to 2031]:

Psychotic Disorder Treatment Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Psychotic Disorder Treatment Market

The psychotic disorder treatment market is witnessing a profound transformation, driven by an escalating global prevalence of mental health conditions, increasing awareness, and significant advancements in pharmacotherapy and digital health solutions. This evolution is marked by a shift towards more targeted, patient-centric, and accessible treatment options, aiming to improve adherence and long-term outcomes for individuals living with conditions like schizophrenia and bipolar disorder.

Features of the Global Psychotic Disorder Treatment Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Psychotic Disorder Treatment Market by Drug Type

5. Global Psychotic Disorder Treatment Market by Indication

6. Global Psychotic Disorder Treatment Market by Distribution Channel

7. Regional Analysis

8. North American Psychotic Disorder Treatment Market

9. European Psychotic Disorder Treatment Market

10. APAC Psychotic Disorder Treatment Market

11. ROW Psychotic Disorder Treatment Market

12. Competitor Analysis

13. Opportunities & Strategic Analysis

14. Company Profiles of the Leading Players Across the Value Chain

15. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기